MedTrace Logo

Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects

NCT05478382 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2022-07-28

No results posted yet for this study

Summary

The objective of this study is to examine the efficacy and side effect of varying dose of pregabalin for the treatment of postoperative pain after spinal surgery.

Conditions

  • Postoperative Pain
  • Pregabalin
  • Spine Surgery
  • Adverse Reaction to Pregabalin

Interventions

DRUG

Pregabalin 25 MG

Patients are given 0 to 3 capsules per administration according to their allocated group.

DRUG

Placebo

Patients are given 0 to 3 capsules per administration according to their allocated group.

Sponsors & Collaborators

  • HK inno.N Corporation

    collaborator INDUSTRY

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Han-Dong Lee, Prof. · Ajou University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05478382 on ClinicalTrials.gov